SELLAS Life Sciences Group, Inc.

SLS - CIK 0001390478

Market cap$1.44 B

Rank#2371

SEC filings1,262

SLS income statement (quarterly)

The table below shows SELLAS Life Sciences Group, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.

Line item	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024
Revenue	-	-	-	-	-	-
Cost of revenue	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Gross profit	-	-	-	-	-	-
R&D	-	-	-	-	-	-
SG&A

SLS annual revenue (10-K history)

SELLAS Life Sciences Group, Inc. reported annual revenue of $0.00 for fiscal year 2023. That is down 100.0% from $1.00M in fiscal 2022. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.